1. Fahie-Wilson, MN, John, R, Ellis, AR, et al. Macroprolactin; high molecular mass forms of circulating prolactin. Ann Clin Biochem Int J Lab Med 2005; 42: 175–192.
Google Scholar | SAGE Journals | ISI2. Hattori, N, Aisaka, K, Shimatsu, A. A possible cause of the variable detectability of macroprolactin by different immunoassay systems. Clin Chemistry Laboratory Medicine 2016; 54: 603–608.
Google Scholar | Crossref | Medline3. Samson, S, Hamrahian, AH, Ezzat, S, et al American Association of Clinical Endocrinologists, American College of Endocrinology Disease State Clinical Review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr Pract 2015; 21: 1427–1435.
Google Scholar | Crossref | Medline4. Smith, TP, Suliman, AM, Fahie-Wilson, MN, et al. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 2002; 87: 5410–5415.
Google Scholar | Crossref | Medline | ISI5. McCudden, CR, Sharpless, JL, Grenache, DG. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin. Clinica Chim Acta 2010; 411: 155–160.
Google Scholar | Crossref | Medline6. Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 273–288.
Google Scholar | Crossref | Medline | ISI7. Gibney, J, Smith, TP, McKenna, TJ. Clinical relevance of macroprolactin. Clin Endocrinol 2005; 62: 633–643.
Google Scholar | Crossref | Medline | ISI8. Fahie-Wilson, M, Smith, TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab 2013; 27: 725–742.
Google Scholar | Crossref | Medline | ISI9. Horowitz, GL, Altaie, S, Boyd, JC, et al. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2008, p. 76.
Google Scholar10. Solberg, HE . International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clinica Chim Acta 1987; 170: S13–S32.
Google Scholar | Crossref | ISI11. Parlant-Pinet, L, Harthé, C, Roucher, F, et al. Macroprolactinaemia: a biological diagnostic strategy from the study of 222 patients. Eur J Endocrinol 2015; 172: 687–695.
Google Scholar | Crossref | Medline12. Overgaard, M, Pedersen, SM. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia. Clin Chemistry Laboratory Medicine 2017; 55: 1744–1753.
Google Scholar | Crossref | Medline13. Saleem, M, Martin, H, Coates, P. Prolactin biology and laboratory measurement: an update on physiology and current analytical issues. Clin Biochem Rev 2018; 39: 3–16.
Google Scholar | Medline14. Farzami, MR, Aliasgharpour, M. Chemiluminescence systems; do all lead to same results in prolactin analysis?. J Diabetes Metab Disord 2017; 16: 24.
Google Scholar | Crossref | Medline15. Veljkovic, K, Servedio, D, Don-Wauchope, AC. Reporting of post-polyethylene glycol prolactin: precipitation by polyethylene glycol 6000 or polyethylene glycol 8000 will change reference intervals for monomeric prolactin. Ann Clin Biochem Int J Lab Med 2012; 49: 402–404.
Google Scholar | SAGE Journals | ISI